Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01560923
Title Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois Medical Center Chicago Illinois 60612 United States Details
Masonic Cancer Center, University of Minnesota Minneapolis Minnesota 55455 United States Details
New York Presbyterian/Weill Cornell Medical Center New York New York 10065 United States Details
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field